Please join Julia Charlton for a webinar on Listing Biotech, Specialist Technology and WVR-structured Companies on the Hong Kong Stock Exchange at 4:30 to 6:00 pm HKT on 11 September 2026.
The webinar is accredited with 1.5 CPD points by The Law Society of Hong Kong.
Level: Beginner/Intermediate
Webinar Objective:
The webinar will provide a detailed introduction to the requirements for listing biotech, specialist technology and WVR-structured companies on the HKEX, including the changes to the Listing Rules that took effect on 24 July 2026.
About the Webinar
The webinar will cover the following topics:
- Background to the special listing regimes
- Chapter 18A: Biotech Companies:
- Conditions & suitability for listing
- Core products & developmental milestones
- Listing document disclosure & continuing obligations
- Chapter 18C: Specialist Technology Companies:
- Specialist technology industries
- Financial, R&D & Sophisticated Independent Investor Requirements
- Listing document disclosure & continuing obligations
- Chapter 8A: WVR Structures
- Definition, financial eligibility & Innovative Company requirements
- WVR mechanics, governance & overseas issuers
- July 2026 Listing Rule amendments
- Revised WVR financial tests & Innovative Company requirements
- Biotech & Specialist Technology Companies meeting Ch 8 financial tests permitted to list under Chs 18A & 18C
About the Presenter
Julia Charlton is a Hong Kong and English qualified solicitor and has been practising law in Hong Kong since 1987. She is the founder and a partner of Charltons, a boutique Hong Kong law firm focusing on corporate finance. Julia practises as a corporate finance lawyer and has extensive experience of advising Hong Kong, Chinese and overseas businesses and financial institutions on capital raisings, M&A, investment and business activities in Hong Kong, China and internationally. Her practice areas include Hong Kong IPOs, listed companies’ regulatory compliance, capital markets, derivatives, securities law, investment funds, virtual assets, stablecoins, restructuring, private equity and regulatory issues, and general corporate and commercial matters.
- Enrolment is limited – enrolments will be accepted on a first-come-first-served basis.
- Please note that we accept no liability for any non-availability for any CPD Point(s) for any participants whatsoever.
- A confirmation of attendance based on your registration and log in and out details will be sent to you automatically via email shortly after the webinar ends. No other or further confirmation will be provided.